Works matching IS 03065251 AND DT 2013 AND VI 75 AND IP 5

Results: 27

Neuropeptides and diabetic retinopathy.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1189, doi. 10.1111/bcp.12003

By:

Gábriel, Robert

Publication type:

Article

Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteers.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1299, doi. 10.1111/j.1365-2125.2012.04472.x

By:

Othman, Ahmed A.;
Haig, George;
Florian, Hana;
Locke, Charles;
Zhang, Jun;
Dutta, Sandeep

Publication type:

Article

Pharmacokinetics and central nervous system effects of the novel dual NK1/NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1328, doi. 10.1111/bcp.12004

By:

te Beek, Erik T.;
Hay, Justin L.;
Bullman, Jonathan N.;
Burgess, Clare;
Nahon, Kimberly J.;
Klaassen, Erica S.;
Gray, Frank A.;
Gerven, Joop M. A.

Publication type:

Article

Response to the comments from Drs Shimazawa and Ikeda.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1368, doi. 10.1111/j.1365-2125.2012.04461.x

By:

Shah, Rashmi R.;
Shah, Devron R.

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. i, doi. 10.1111/j.1365-2125.2012.04432.x
Publication type:: Article

Authors' response to Marras and Oakes, 'piecing together the puzzle of progression and mortality in Parkinson's disease'.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1370, doi. 10.1111/j.1365-2125.2012.04465.x

By:

Holford, Nicholas H. G.;
Vu, Thuy C.;
Nutt, John G.

Publication type:

Article

Analgesia and central side-effects: two separate dimensions of morphine response.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1340, doi. 10.1111/bcp.12008

By:

Droney, Joanne M.;
Gretton, Sophy K.;
Sato, Hiroe;
Ross, Joy R.;
Branford, Ruth;
Welsh, Kenneth I.;
Cookson, William;
Riley, Julia

Publication type:

Article

Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantation.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1277, doi. 10.1111/bcp.12007

By:

Musuamba, Flora T.;
Mourad, Michel;
Haufroid, Vincent;
De Meyer, Martine;
Capron, Arnaud;
Delattre, Isabelle K.;
Verbeeck, Roger K.;
Wallemacq, Pierre

Publication type:

Article

Bad Pharma: how drug companies mislead doctors and harm patients - By Ben Goldacre.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1377, doi. 10.1111/bcp.12047

By:

Rang, Humphrey

Publication type:

Article

Half-life prolongation of therapeutic proteins by conjugation to ATIII-binding pentasaccharides: a first-in-human study of Carbo Carrier® insulin.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1221, doi. 10.1111/j.1365-2125.2012.04460.x

By:

Miltenburg, André M. M.;
Prohn, Marita;
Kuijk, Jacqueline H. M.;
Tiessen, Renger G.;
Kort, Martin;
Berg, Rob J. W.

Publication type:

Article

A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1231, doi. 10.1111/bcp.12018

By:

Moss, Donald E.;
Fariello, Ruggero G.;
Sahlmann, Jörg;
Sumaya, Isabel;
Pericle, Federica;
Braglia, Enrico

Publication type:

Article

Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics - results from single oral dose studies in healthy volunteers.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1240, doi. 10.1111/j.1365-2125.2012.04471.x

By:

Stoch, S. Aubrey;
Zajic, Stefan;
Stone, Julie A.;
Miller, Deborah L.;
Bortel, Lucas;
Lasseter, Kenneth C.;
Pramanik, Barnali;
Cilissen, Caroline;
Liu, Qi;
Liu, Lida;
Scott, Boyd B.;
Panebianco, Deborah;
Ding, Yu;
Gottesdiener, Keith;
Wagner, John A.

Publication type:

Article

Author reply to Holford, Vu and Nutt regarding 'piecing together the puzzle of progression and mortality in Parkinson's disease'.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1372, doi. 10.1111/j.1365-2125.2012.04464.x

By:

Marras, Connie;
Oakes, David

Publication type:

Article

Antidepressant use and gestational hypertension: does evidence support causality?

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1373, doi. 10.1111/j.1365-2125.2012.04468.x

By:

Grzeskowiak, Luke E.;
Pedersen, Lars H.;
Morrison, Janna L.

Publication type:

Article

Antidepressant use and gestational hypertension: does evidence support causality? Reply letter.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1375, doi. 10.1111/bcp.12020

By:

Bérard, Anick;
De Vera, Mary A.

Publication type:

Article

Vitamin D3 supplementation scheme in HIV-infected patients based upon pharmacokinetic modelling of 25-hydroxycholecalciferol.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1312, doi. 10.1111/bcp.12006

By:

Foissac, Frantz;
Tréluyer, Jean‐Marc;
Souberbielle, Jean‐Claude;
Rostane, Hafeda;
Urien, Saïk;
Viard, Jean‐Paul

Publication type:

Article

Pharmacokinetics of 450 mg ropivacaine with and without epinephrine for combined femoral and sciatic nerve block in lower extremity surgery. A pilot study Pharmacokinetics of 450 mg ropivacaine with and without epinephrine for combined femoral and sciatic nerve block in lower extremity surgery. A pilot study

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1321, doi. 10.1111/j.1365-2125.2012.04470.x

By:

Schoenmakers, Karin P. W.;
Vree, Tom B.;
Jack, Nigel T. M.;
Bemt, Bart;
Limbeek, Jacques;
Stienstra, Rudolf

Publication type:

Article

Sir David Jack: an extraordinary drug discoverer and developer.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1213, doi. 10.1111/j.1365-2125.2012.04467.x

By:

Page, Clive;
Humphrey, Patrick

Publication type:

Article

Applied clinical pharmacology and public health in rural Asia - preventing deaths from organophosphorus pesticide and yellow oleander poisoning.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1175, doi. 10.1111/j.1365-2125.2012.04449.x

By:

Eddleston, Michael

Publication type:

Article

Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1356, doi. 10.1111/bcp.12001

By:

Pottegård, Anton;
Friis, Søren;
Andersen, Morten;
Hallas, Jesper

Publication type:

Article

Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1202, doi. 10.1111/bcp.12012

By:

Hu, Li‐jun;
Chen, Yun‐qing;
Deng, Song‐bai;
Du, Jian‐lin;
She, Qiang

Publication type:

Article

Clinical pharmacology in health care, teaching and research.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1219, doi. 10.1111/bcp.12074

By:

Rawlins, Michael D.

Publication type:

Article

Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1351, doi. 10.1111/bcp.12005

By:

Biagi, Chiara;
Venegoni, Mauro;
Melis, Mauro;
Buccellato, Elena;
Montanaro, Nicola;
Motola, Domenico

Publication type:

Article

Bioequipotency of idraparinux and idrabiotaparinux after once weekly dosing in healthy volunteers and patients treated for acute deep vein thrombosis.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1255, doi. 10.1111/bcp.12009

By:

Trellu, Marc;
Fau, Jean‐Baptiste;
Cortez, Pierre;
Cheng, Sue;
Paty, Isabelle;
Boëlle, Emmanuelle;
Donat, François;
Sanderink, Ger‐Jan

Publication type:

Article

Are there any differences in the regulations of personalized medicine among the USA, EU and Japan?

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1365, doi. 10.1111/j.1365-2125.2012.04462.x

By:

Shimazawa, Rumiko;
Ikeda, Masayuki

Publication type:

Article

Prophylactic ranitidine treatment in critically ill children - a population pharmacokinetic study.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1265, doi. 10.1111/j.1365-2125.2012.04473.x

By:

Hawwa, Ahmed F.;
Westwood, Paul M.;
Collier, Paul S.;
Millership, Jeffrey S.;
Yakkundi, Shirish;
Thurley, Gillian;
Shields, Mike D.;
Nunn, Anthony J.;
Halliday, Henry L.;
McElnay, James C.

Publication type:

Article

Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody ( CNTO 5825) in an ascending single-dose first-in-human study.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1289, doi. 10.1111/j.1365-2125.2012.04477.x

By:

Hartingsveldt, Bart;
Nnane, Ivo P.;
Bouman‐Thio, Esther;
Loza, Matthew J.;
Piantone, Alexa;
Davis, Hugh M.;
Petty, Kevin J.

Publication type:

Article

Works matching IS 03065251 AND DT 2013 AND VI 75 AND IP 5

Neuropeptides and diabetic retinopathy.

Safety, tolerability and pharmacokinetics of the histamine H<sub>3</sub> receptor antagonist, ABT-288, in healthy young adults and elderly volunteers.

Pharmacokinetics and central nervous system effects of the novel dual NK<sub>1</sub>/NK<sub>3</sub> receptor antagonist GSK1144814 in alcohol-intoxicated volunteers.

Response to the comments from Drs Shimazawa and Ikeda.

Issue Information.

Authors' response to Marras and Oakes, 'piecing together the puzzle of progression and mortality in Parkinson's disease'.

Analgesia and central side-effects: two separate dimensions of morphine response.

Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantation.

Bad Pharma: how drug companies mislead doctors and harm patients - By Ben Goldacre.

Half-life prolongation of therapeutic proteins by conjugation to ATIII-binding pentasaccharides: a first-in-human study of Carbo Carrier<sup>®</sup> insulin.

A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease.

Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics - results from single oral dose studies in healthy volunteers.

Author reply to Holford, Vu and Nutt regarding 'piecing together the puzzle of progression and mortality in Parkinson's disease'.

Antidepressant use and gestational hypertension: does evidence support causality?

Antidepressant use and gestational hypertension: does evidence support causality? Reply letter.

Vitamin D<sub>3</sub> supplementation scheme in HIV-infected patients based upon pharmacokinetic modelling of 25-hydroxycholecalciferol.

Sir David Jack: an extraordinary drug discoverer and developer.

Applied clinical pharmacology and public health in rural Asia - preventing deaths from organophosphorus pesticide and yellow oleander poisoning.

Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study.

Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis.

Clinical pharmacology in health care, teaching and research.

Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database.

Bioequipotency of idraparinux and idrabiotaparinux after once weekly dosing in healthy volunteers and patients treated for acute deep vein thrombosis.

Are there any differences in the regulations of personalized medicine among the USA, EU and Japan?

Prophylactic ranitidine treatment in critically ill children - a population pharmacokinetic study.

Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody ( CNTO 5825) in an ascending single-dose first-in-human study.